Сongenital infantile fibrosarcoma with a non-canonical TPM3-NTRK1 fusion transcript: a case report and a literature review
Open Access
- 22 December 2021
- journal article
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 20 (4) , 110-120
Abstract
Infantile fibrosarcoma (IFS) is a rare malignant soft tissue tumor characterized by local invasion, a low rate of distant metastasis (1–13%), and manifestation during the first years of life. Overall survival rates range from 89 to 94%, event-free survival rates – from 81 to 84%. Classic IFS is characterized by t(12;15)(p13;q25) translocation resulting in the formation of the ETV6-NTRK3 fusion transcript. However, over the past few years, there have been numerous reports of IFS-like tumors with non-canonical genetic aberrations (BRAF, NTRK1, MET genes) whose prognosis is less predictable. Here we report a rare case of congenital IFS with involvement of subcutaneous fat, indolent course and a non-canonical TPM3-NTRK1 fusion transcript identified in the soft tissue and intradermal tumor components with different histological features. The patient’s parents gave their consent to the use of their child’s data, including photographs, for research purposes and in publications. The literature review explores modern algorithms for the diagnosis and treatment of IFS in children, including the use of new therapies, such as tropomyosin receptor kinase inhibitors, as well as algorithms for detecting NTRK1, NTRK2, NTRK3 gene rearrangements in solid neoplasms in general, and soft tissue tumors in particular.Keywords
This publication has 23 references indexed in Scilit:
- A novel group of spindle cell tumors defined by S100 and CD34 co‐expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genesGenes, Chromosomes and Cancer, 2018
- The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomasCancer, 2018
- Evaluation of pan‐TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis‐like neural tumour and histological mimicsHistopathology, 2018
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyThe Lancet Oncology, 2018
- Infantile NTRK-associated Mesenchymal TumorsPediatric and Developmental Pathology, 2017
- Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural TumorsAmerican Journal of Surgical Pathology, 2016
- Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experienceEuropean Journal of Cancer, 2016
- Clinical management of infantile fibrosarcoma: a retrospective single-institution reviewPediatric Surgery International, 2013
- Infantile Fibrosarcoma: Management Based on the European ExperienceJournal of Clinical Oncology, 2010
- A novel ETV6-NTRK3 gene fusion in congenital fibrosarcomaNature Genetics, 1998